316 research outputs found
Studying WholeâMounted Sections of the Paranasal Sinuses to Understand the Complications of Endoscopic Sinus Surgery
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/136288/1/lary19911014361.pd
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Relapse is a major cause of treatment failure after allogeneic hematopoietic stem cell transplantation (alloHSCT). Treatment options for relapse have been inadequate, and the majority of patients ultimately die of their disease. There is no standard approach to treating relapse after alloHSCT. Withdrawal of immune suppression and donor lymphocyte infusions are commonly used for all diseases; although these interventions are remarkably effective for relapsed chronic myelogenous leukemia, they have limited efficacy in other hematologic malignancies. Conventional and novel chemotherapy, monoclonal antibody therapy, targeted therapies, and second transplants have been utilized in a variety of relapsed diseases, but reports on these therapies are generally anecdotal and retrospective. As such, there is an immediate need for well-designed, disease-specific trials for treatment of relapse after alloHSCT. This report summarizes current treatment options under investigation for relapse after alloHSCT in a disease-specific manner. In addition, recommendations are provided for specific areas of research necessary in the treatment of relapse after alloHSCT
National Cancer Instituteâs First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Summary and Recommendations from the Organizing Committee
The National Cancer Instituteâs First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation was organized and convened to identify, prioritize, and coordinate future research activities related to relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Each of the Workshopâs 6 Working Committees has published individual reports of ongoing basic, translational, and clinical research and recommended areas for future research related to the areas of relapse biology, epidemiology, prevention, and treatment. This document summarizes each committeeâs recommendations and suggests 3 major initiatives for a coordinated research effort to address the problem of relapse after allo-HSCT: (1) to establish multicenter correlative and clinical trial networks for basic/translational, epidemiologic, and clinical research; (2) to establish a network of biorepositories for the collection of samples before and after allo-HSCT to aid in laboratory and clinical studies; and (3) to further refine, implement, and study the Workshop-proposed definitions for disease-specific response and relapse and recommendations for monitoring of minimal residual disease. These recommendations, in coordination with ongoing research initiatives and transplantation organizations, provide a research framework to rapidly and efficiently address the significant problem of relapse after allo-HSCT
Muon `Depth -- Intensity' Relation Measured by LVD Underground Experiment and Cosmic-Ray Muon Spectrum at Sea Level
We present the analysis of the muon events with all muon multiplicities
collected during 21804 hours of operation of the first LVD tower. The measured
angular distribution of muon intensity has been converted to the `depth --
vertical intensity' relation in the depth range from 3 to 12 km w.e.. The
analysis of this relation allowed to derive the power index, , of the
primary all-nucleon spectrum: . The `depth -- vertical
intensity' relation has been converted to standard rock and the comparison with
the data of other experiments has been done. We present also the derived
vertical muon spectrum at sea level.Comment: 7 pages, 3 figures, to be published on Phys. Rev.
Upper Limit on the Prompt Muon Flux Derived from the LVD Underground Experiment
We present the analysis of the muon events with all muon multiplicities
collected during 21804 hours of operation of the first LVD tower. The measured
depth-angular distribution of muon intensities has been used to obtain the
normalization factor, A, the power index, gamma, of the primary all-nucleon
spectrum and the ratio, R_c, of prompt muon flux to that of pi-mesons - the
main parameters which determine the spectrum of cosmic ray muons at the sea
level. The value of gamma = 2.77 +/- 0.05 (68% C.L.) and R_c < 2.0 x 10^-3 (95%
C.L.) have been obtained. The upper limit to the prompt muon flux favours the
models of charm production based on QGSM and the dual parton model.Comment: 10 pages, 4 figures, RevTex. To appear in Phys. Rev.
Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation
Host macrophages protect against graft-versus-host disease in part by engulfing donor T cells and inhibiting their proliferation
- âŠ